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G. Alakpa,(1>2) A. F. Fagbenro-Beyioku(1,2) and S. C. Clarkec3) 
Background: Cyclosporu cuyetunensis is an emerging human pathogen associated with gastrointestinal disease. The 
epidemiology and biology of the parasite are poorly understood, and numerous outbreaks of cyclosporiasis have been 
recorded from around the world since 1990, but the incidence of the parasite in Nigeria has not been described. 
Design and methods: A cross-sectional, laboratory-based study was conducted in Lagos-metropolis state in south- 
western Nigeria. All stool samples submitted to the Microbiology and Parasitology Department between March 1999 
and April 2000 were processed for the presence of Cyclospora cuyetanensis. Data from each patient were obtained 
from health records and via questionnaires, including age, sex and reason for hospital visit. 
Results: In total, 1109 stool samples were collected during the period of study. Eleven (0.99%) were confirmed to 
be positive for Cyclospora cuyetunensis oocysts. Other parasites were also detected, including Cryptosporidium sp., 
Entumoeba sp., Ascuris, Trichuris, Strongyloides sp., and hookworm. 
Conclusions: Cyclosporu cuyetanensis is an infrequent but important cause of gastrointestinal disease in Lagos, 
Nigeria. This is the first report of Cyclosporu infection in Nigeria and suggests that medical practitioners and labora- 
tory scientists should be made more aware of the infection. 
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INTRODUCTION 
The organism Cyclosporu cayetunensis is an emerging 
human pathogen associated with gastrointestinal or diar- 
rhea1 conditions.14 It remains the only species of the 
genus Cyclosporu known to cause infection in both 
immunocompromised and immunocompetent indi- 
viduals. Other symptoms associated with its infection are 
nausea, vomiting, anorexia, weight loss, abdominal pain, 
tenensmus, flatulence, muscle and joint pains, headache 
and fever.‘-’ Pathologically, infection may lead to villous 
blunting, villous atrophy, crypt hyperplasia, focal vacuo- 
lation of the surface of the epithelium, and acute inflam- 
mation of the lamina propria.8,9 
The epidemiology, biology and infectious dose of 
the organism are still speculative. Its route of trans- 
mission is not entirely certain, but is most likely the 
fecal-oral route, with water and food produce, especially 
vegetables, as the most implicated vehicles for its spread. 
Infection occurs following the ingestion of a sporu- 
lated oocyst2,’ Diagnosis of infection is routinely by 
microscopic examination of fecal or intestinal biopsy 
specimens, with the oocyst exhibiting a characteristic 
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autofluorescence under ultraviolet light. When stained 
with the modified Kinyoun carbolfuchsin (acid-fast) stain, 
the oocyst appears red or colorless, measuring between 
8 and 10 pm in diameter.iO*” Infection can be effectively 
treated with trimethoprim-sulfamethoxazole. 
Cyclosporiasis was first detected and associated with 
diarrhea1 and gastrointestinal conditions in humans in 
1979,l* and numerous outbreaks of cyclosporiasis have 
been reported since 1990. The 1996 and 1997 outbreaks 
in the USA and Canada stimulated scientists, health 
workers, institutions and even governments of some 
countries to become concerned about this pathogen.13-20 
The incidence of cyclosporiasis has been reported 
from most continents, making it a global infection.4,21-25 
From Africa, only three countries have so far been 
documented to report the detection of the pathogen’s 
oocysts from patients with diarrhea. These countries are 
Egypt,‘j Morocco* and South Africa.*‘j The aim of this 
study was therefore to investigate the presence of Cyclo- 
sporu cuyetunensis in Lagos, Nigeria by screening stool 
samples submitted to some major hospitals’ laboratories, 
and to determine the symptoms associated with the pre- 
sentation of illness. 
MATERIALS AND METHODS 
Location of study and sample collection centers 
This was a cross-sectional, laboratory-based study con- 
ducted in Lagos-metropolis, a state in the southwestern 
part of Nigeria, bound in the east by Ondo State, in the 
north and west by Ogun State, and in the south by the 
Atlantic ocean. It is the most populated state in Nigeria 
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and the commercial center of the country. The centers 
from which stool samples were collected were: The Yaba 
Central Laboratory; Nigerian Army Base Hospital; the 
General Hospital, Lagos; the Lagos University Teaching 
Hospital; Jimsan Hospital, Ijora-Badiya; and two private 
laboratories. 
Controls 
Healthy individuals, with no prior illness (gastrointestinal 
or diarrheal) from 3 weeks to the time at which the 
stool sample was collected, served as negative controls. 
Positive control slides were prepared and supplied by Dr 
Clarke. 
Collection of samples 
All stool samples submitted to the Microbiology and 
Parasitology Departments of the above-mentioned 
health institutions between March 1999 and April 2000 
were collected in waterproof screw-capped plastic 
containers and transferred to the laboratory for 
processing. In total, 1109 stool samples were collected 
during the period of this study. Bio-data of the patients 
whose stools were collected were obtained from health 
records and by means of questionnaires. Data including 
the age, sex and reason for visiting the hospital were also 
collected. 
Stool processing 
Stool samples were processed immediately upon arrival. 
When delay was expected, stools were initially preserved 
with 10% formalin, but this was later changed to 2.5% 
potassium dichromate solution. Samples were concen- 
trated by the formal saline ethyl acetate sedimentation 
method. Smears were made on grease-free clean slides 
from concentrated stool samples and later stained by 
the modified Kinyoun carbolfuchsin staining procedure. 
Stained smears were examined at x400 magnification 
using the Nikon light microscope equipped with an eye- 
piece micrometer calibrated using a stage micrometer, 
to determine the size of the oocyst. 
Identification of oocysts 
Oocyst identification was based on criteria including the 
size of the oocyst (8-10 pm in diameter), the shape and 
morphology (oval/round with well-defined wall), and the 
staining characteristics (inconsistent staining, pink-red 
to colorless).3.27 
Statistical analysis 
Results were analyzed with Epi-Info 6.4 version and the 
STAT statistical software packages. The chi-square and 
Student t-tests were used to determine the statistical 
significance at a 95% confidence level. 
RESULTS 
Stool frequency distribution by age, sex and 
nature of stool 
One thousand, one hundred and nine (1109) stool 
samples were received. The frequency distribution of the 
stools showed that 80.9% (897) were collected from 
individuals aged 21-50 years, 7.5% (83) from those aged 
11-20 years, 3.8% (42) from children aged O-5 years, 
2.8% (31) from those aged 251 years, and 2.2% (24) 
from those aged 6-10 years. The mean age of patients 
whose stool samples were collected was 30 years (+ 13) 
for females and 28 years (2 14) for males. 
Five hundred and sixty (51.3%) of the stool samples 
were from males and 463 (41.7%) from females. Four 
hundred and forty-five (40%) were ‘soft’ in consistency, 
430 (40%) were ‘hard’ formed, and 225 (20%) were 
watery. Of the 1109 stools, 19.5% were from patients 
with diarrhea (defined as passing three or more watery 
stools in 24 h). The majority of stools (59.8%) were 
received for routine stool examination, 19.4% were 
from those with gastrointestinal complaints, and 16.1% 
were from HIV-positive patients whose stools were 
collected based on special request. 
Relating the bio-data of patients and their reasons 
for the submission of stool for laboratory investigation, 
59.8% of the 1109 came from those undergoing routine 
investigation, and 19.4% were from those with gastro- 
intestinal complaints. 
Frequency of Cyclospora infection and association 
with age and sex 
Of the 1109 stool samples analyzed, 11 (0.99%) were 
confirmed to be positive for Cyclospora cayetanensis 
oocysts. In all these, the cyclospora oocysts were 8- 
9.5 km in diameter and stained variably with the carbol- 
fuchsin stain. They also demonstrated autofluorescence 
under ultraviolet light. Other parasites were also 
detected, including Cryptosporidium sp., Entamoeba sp., 
Ascaris, Trichuris, Strongyloides sp., and hookworm. 
The mean age of patients whose stools were positive 
for Cyclospora oocysts was 30 years (? 13). All patients 
were aged between 21 and 50 years. Eight of these stools 
came from females and three from males. Ten were from 
diarrhea1 patients and one was from a non-diarrhea1 
patient, whose stool was submitted following gastro- 
intestinal complaints. Four of the 11 positive stools were 
from patients with gastrointestinal complaints, and the 
remaining four were from HIV-seropositive individuals 
(Table 1). Patients from whom four of the stools were 
submitted had multiple infections with other intestinal 
parasites such as Cryptosporidium parvum, Ascaris or 
Entamoeba coli. None had any infection with patho- 
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Table 1. Distribution of stools with the detection of Cyclospora 
oocysts 
Variables 
Age group 
O-5 years 
6-10 years 
1 l-20 years 
21-50 years 
251 years 
Not stated 
Sex 
Female 
Male 
Not stated 
Nature of stool 
Hard 
Soft 
Watery 
Not recorded 
Reasons 
Routine 
Gastrointestinal 
HIV testing 
Check-up 
Control 
Others 
Diarrhea 
Yes 
No 
Total 
Positive Negative 
0 42 
0 24 
0 83 
11 886 
0 31 
0 32 
8 455 
3 566 
0 77 
0 439 
1 454 
10 204 
0 1 
0 663 
4 211 
7 172 
0 11 
0 25 
0 16 
10 206 
1 892 
11 1089 
genie bacteria. Significant relationships (PcO.05) were 
found between the detection of Cyclospora oocysts, the 
diarrhea1 status of the patient and the nature of the 
stool, and also between oocyst detection, diarrhea1 status 
and nature of stool. However, there was no significant 
statistical relationship (P>O.O5) between the detection 
of the Cyclosporu oocysts and age, sex or reasons for 
visiting hospital. Unfortunately, there were insufficient 
data on the course of diarrhea in patients with Cyclo- 
sporu infection. 
DISCUSSION 
Cyclosporu cuyetunensis infection (cyclosporiasis) has 
been reported from virtually all of the continents of 
the world, and has been implicated in gastrointestinal 
illness.2”~s~15~25~26~28-33 Results from this laboratory-based 
study reveal, for the first time, the presence of this 
emerging pathogenic diarrhea1 protozoan in stool 
samples in Lagos State, Nigeria. Like others, this study 
showed the possible association with and implication 
of this pathogen in diarrhea1 cases in this part of the 
country. All those patients from whose stools Cyclosporu 
oocysts were detected were adults, and all stools but one 
were diarrheal. The prevalence of 0.99% recorded here 
is similar to those previously reported.4,6,8,15,23,25,30,31 
Although there was no significant association 
between the detection of the pathogen’s oocyst and age, 
all positive stools were from adults aged between 22 
and 46 years. This is similar to results obtained in some 
studies,4,6,8J5,25 but different from results obtained in 
others.23,28,31 This may be attributed to the fact that Lagos 
State may not yet have endemic Cyclosporu infection. 
This would also be responsible for the 0.99% prevalence 
observed in this study, which is similar to the prevalence 
reported by others.4%31 
The significant association between the reason for 
stool submission and the detection of Cyclosporu oocysts 
is interesting, as it raises the question as to whether this 
factor can be used as a diagnostic parameter for the 
investigation of Cyclosporu cuyetunensis. A suggestion is 
that all stool samples submitted for laboratory analysis 
in Lagos, Nigeria be screened for Cyclosporu oocysts. 
The results from this study have identified and 
confirmed the existence of Cyclosporu cuyetanensis in 
Lagos and shown its significant association with diar- 
rhea1 cases. Global travel has increased in recent years, 
and changes have occurred in Nigerian eating habits 
(from African foods to international cuisine). These are 
just two factors that may expose Nigerians to the risk 
of Cyclospora infection. More studies are required to 
determine the incidence of Cyclospora in Nigeria and 
the rest of Africa, and also to educate medical practi- 
tioners and laboratory scientists in these countries. 
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